Christopher Seder to Prognosis
This is a "connection" page, showing publications Christopher Seder has written about Prognosis.
Connection Strength
0.701
-
Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma. Anticancer Res. 2018 04; 38(4):2195-2200.
Score: 0.126
-
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
Score: 0.121
-
Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus. Anticancer Res. 2015 Nov; 35(11):6159-62.
Score: 0.106
-
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma. Anticancer Res. 2015 Nov; 35(11):6325-7.
Score: 0.106
-
The safe transition from open to thoracoscopic lobectomy: a 5-year experience. Ann Thorac Surg. 2009 Jul; 88(1):216-25; discussion 225-6.
Score: 0.068
-
Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia. 2009 Apr; 11(4):388-96.
Score: 0.067
-
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
Score: 0.041
-
Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung. Interact Cardiovasc Thorac Surg. 2021 11 22; 33(6):879-884.
Score: 0.040
-
Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
Score: 0.025